Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Tubulin/HDAC-IN-1

😃Good
Catalog No. T61524Cas No. 2413587-26-3

Tubulin/HDAC-IN-1 is a dual inhibitor of tubulin and HDAC8, interacting with tubulin via CH/π interactions and with HDAC8 through hydrogen bonds. It effectively inhibits tubulin polymerization and selectively targets HDAC8 with an IC50 of 150 nM. Additionally, Tubulin/HDAC-IN-1 demonstrates cytotoxicity against various human cancer cells, induces cell cycle arrest in the G2/M phase, and triggers cell apoptosis, making it valuable for studying hematologic and solid tumors, including neuroblastoma and leukemia [1].

Tubulin/HDAC-IN-1

Tubulin/HDAC-IN-1

😃Good
Catalog No. T61524Cas No. 2413587-26-3
Tubulin/HDAC-IN-1 is a dual inhibitor of tubulin and HDAC8, interacting with tubulin via CH/π interactions and with HDAC8 through hydrogen bonds. It effectively inhibits tubulin polymerization and selectively targets HDAC8 with an IC50 of 150 nM. Additionally, Tubulin/HDAC-IN-1 demonstrates cytotoxicity against various human cancer cells, induces cell cycle arrest in the G2/M phase, and triggers cell apoptosis, making it valuable for studying hematologic and solid tumors, including neuroblastoma and leukemia [1].
Pack SizePriceAvailabilityQuantity
25 mg$1,520 6-8 weeks
50 mg$1,980 6-8 weeks
100 mg$2,500 6-8 weeks
Bulk & Custom
Add to Cart
Questions
View More
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Tubulin/HDAC-IN-1 is a dual inhibitor of tubulin and HDAC8, interacting with tubulin via CH/π interactions and with HDAC8 through hydrogen bonds. It effectively inhibits tubulin polymerization and selectively targets HDAC8 with an IC50 of 150 nM. Additionally, Tubulin/HDAC-IN-1 demonstrates cytotoxicity against various human cancer cells, induces cell cycle arrest in the G2/M phase, and triggers cell apoptosis, making it valuable for studying hematologic and solid tumors, including neuroblastoma and leukemia [1].
In vitro
Tubulin/HDAC-IN-1 (Compound 12a) exhibits pronounced cytotoxicity with an average IC50 of 0.6 nM across various human cancer cell lines. In HT29 cells, 2 nM application induces G2/M phase arrest and caspase-mediated apoptosis via mitochondrial dysfunction over 24 hours. The compound selectively inhibits HDAC8 with an IC50 of 150 nM, and also inhibits HDAC6 and HDAC11 at higher concentrations (1 μM and 1.9 μM, respectively). It increases γH2AX and acetylated SMC3 levels in a dose-dependent manner at 0.5-100 nM, indicating DNA damage and cell stress. Tubulin polymerization is impeded dose-dependently, particularly notable at 5-15 μΜ, and at 250 nM, it disrupts the microtubule network non-specifically. The compound shows good in vitro metabolic stability, observed in intrinsic clearance rates for rat and human liver microsomes. Comprehensive evaluation through cell proliferation assays and western blot analysis in HT-29 cells underscores its potential as a cancer therapeutic agent.
In vivo
Tubulin/HDAC-IN-1 (Compound 12a), administered intratumorally at 0.25 mg/kg three times weekly for two weeks, significantly reduced MCA205 tumor growth and improved overall survival in a C57BL/6 allogeneic sarcoma mouse model. The study [1] also evaluated 0.1 and 0.50 mg/kg dosages, showing decreased tumor growth and extended survival without evident adverse effects.
Chemical Properties
Molecular Weight374.39
FormulaC21H18N4O3
Cas No.2413587-26-3
Storage & Solubility Information
StorageShipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Tubulin/HDAC-IN-1 | purchase Tubulin/HDAC-IN-1 | Tubulin/HDAC-IN-1 cost | order Tubulin/HDAC-IN-1 | Tubulin/HDAC-IN-1 chemical structure | Tubulin/HDAC-IN-1 in vivo | Tubulin/HDAC-IN-1 in vitro | Tubulin/HDAC-IN-1 formula | Tubulin/HDAC-IN-1 molecular weight